Today's Date: March 30, 2011

Gastroenterology

Postoperative nausea and vomiting (PONV) is an unpleasant complication affecting about a third of the 10% of the population undergoing general anesthesia each year.

Therefore Graton Pharma is highly concerned for covering this therapeutic area by introducing Immune suppressants as a countermeasure.

Graton Pharma is committed to develop world-class pharmaceutical products to prevent Nausea and vomiting that can be extremely distressing for patients and is therefore one of their major concerns .On average the incidence of nausea or vomiting after general anesthesia ranges between 25 and 30% .Nausea and vomiting can delay discharge and about 1% of patients scheduled for day surgery require unanticipated overnight admission because of uncontrolled postoperative nausea and vomiting

OUR PRODUCTS:

  • Gratron (Granisetron Hcl) is a selective antagonist of hydroxytryptamine (5HT)3 receptors. It is a potent anti-emetic drug. It is well indicated for post operative chemotherapy and radiotherapy induced nausea and vomiting.
  • Name of manufacturer:  Youcare Pharmaceutical Group Co.Ltd. Beijing, China